Literature DB >> 16236498

Toll-like receptor 2 antagonists. Part 1: preliminary SAR investigation of novel synthetic phospholipids.

Mark R Spyvee1, Huiming Zhang, Lynn D Hawkins, Jesse C Chow.   

Abstract

Novel synthetic phospholipid compound 1 was discovered to be an antagonist of human toll-like receptor 2 (TLR2) signaling. In a preliminary SAR campaign we synthesized several analogues of 1 and found that considerable structural changes could be made without loss of TLR2 antagonistic activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236498     DOI: 10.1016/j.bmcl.2005.08.080

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?

Authors:  Emmanuel Lorne; Hervé Dupont; Edward Abraham
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

Review 2.  Targeting Toll-like receptors with small molecule agents.

Authors:  Xiaohui Wang; Christina Smith; Hang Yin
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

3.  Pattern recognition receptors in equine endotoxaemia and sepsis.

Authors:  A H Werners; C E Bryant
Journal:  Equine Vet J       Date:  2012-05-20       Impact factor: 2.888

Review 4.  Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

Authors:  Luke A J O'Neill; Clare E Bryant; Sarah L Doyle
Journal:  Pharmacol Rev       Date:  2009-05-27       Impact factor: 25.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.